drugset / Trial / NCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

NCT07300969 ↗

Phase 2 Recruiting 300 enrolled Draig Therapeutics Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

Timeline

Start
2025-12-16
Primary completion
2027-08
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject DT-101 Unknown — —